Register entry

Karyopharm Therapeutics Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
6
Live patents
66
Exclusivities
2
Countries
0
Catalogue

Drug listings by form and route

6

6 active NDC listings: 6 human prescription drug. By marketing category: NDA 6.

Dosage formNDCs
tablet, film coated6
RouteNDCs
oral6
Labeller name on the listingNDCs
karyopharm therapeutics inc.6
Exclusivity

Patents and exclusivities

66
PatentProductCoversExpiry
10544108XPOVIOselinexoruseJul 2032
11034660XPOVIOselinexoruseJul 2032
11787771XPOVIOselinexoruseJul 2032
12291508XPOVIOselinexoruseJul 2032
9079865XPOVIOselinexoruseJul 2032
9714226XPOVIOselinexorsubstance, productJul 2032
8999996XPOVIOselinexorsubstance, productJul 2033
10519139XPOVIOselinexorsubstance, productAug 2035
11746102XPOVIOselinexoruseAug 2035
11753401XPOVIOselinexorproductAug 2035
11807629XPOVIOselinexorsubstance, productAug 2035
ProductExclusivityUntil
XPOVIOSELINEXORODE* Orphan drugDec 2027
XPOVIOSELINEXORODE-346 Orphan drugDec 2027
Catalogue

Marketed products

6
BrandGeneric nameForm / routeNDC
XPOVIOselinexortablet, film coated, oral72237-101NDA
XPOVIOselinexortablet, film coated, oral72237-102NDA
XPOVIOselinexortablet, film coated, oral72237-103NDA
XPOVIOselinexortablet, film coated, oral72237-104NDA
XPOVIOselinexortablet, film coated, oral72237-105NDA
XPOVIOselinexortablet, film coated, oral72237-106NDA
Compare

Other companies listing selinexor

Enquiry

Common questions

Is Karyopharm Therapeutics Inc. FDA approved?
Karyopharm Therapeutics Inc. holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Karyopharm Therapeutics Inc. make?
6 products are listed under Karyopharm Therapeutics Inc. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.